Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2005 1
2006 5
2007 13
2008 6
2009 1
2010 4
2011 5
2012 4
2013 16
2014 21
2015 23
2016 33
2017 37
2018 38
2019 35
2020 54
2021 45
2022 40
2023 47
2024 36
2025 35
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

414 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors.
Jubber I, Ong S, Bukavina L, Black PC, Compérat E, Kamat AM, Kiemeney L, Lawrentschuk N, Lerner SP, Meeks JJ, Moch H, Necchi A, Panebianco V, Sridhar SS, Znaor A, Catto JWF, Cumberbatch MG. Jubber I, et al. Among authors: black pc. Eur Urol. 2023 Aug;84(2):176-190. doi: 10.1016/j.eururo.2023.03.029. Epub 2023 May 16. Eur Urol. 2023. PMID: 37198015 Free article.
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
Kamoun A, de Reyniès A, Allory Y, Sjödahl G, Robertson AG, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, Castro MAA, Fontugne J, Eriksson P, Mo Q, Kardos J, Zlotta A, Hartmann A, Dinney CP, Bellmunt J, Powles T, Malats N, Chan KS, Kim WY, McConkey DJ, Black PC, Dyrskjøt L, Höglund M, Lerner SP, Real FX, Radvanyi F; Bladder Cancer Molecular Taxonomy Group. Kamoun A, et al. Among authors: black pc. Eur Urol. 2020 Apr;77(4):420-433. doi: 10.1016/j.eururo.2019.09.006. Epub 2019 Sep 26. Eur Urol. 2020. PMID: 31563503 Free PMC article.
The Financial Burden of Localized and Metastatic Bladder Cancer.
Scilipoti P, Moschini M, Li R, Lerner SP, Black PC, Necchi A, Rouprêt M, Shariat SF, Gupta S, Morgans AK, Psutka SP, Kamat AM. Scilipoti P, et al. Among authors: black pc. Eur Urol. 2025 May;87(5):536-550. doi: 10.1016/j.eururo.2024.12.002. Epub 2024 Dec 26. Eur Urol. 2025. PMID: 39730299
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer.
Galsky MD, Guan X, Rishipathak D, Rapaport AS, Shehata HM, Banchereau R, Yuen K, Varfolomeev E, Hu R, Han CJ, Li H, Liang Y, Vucic D, Wang L, Zhu J, Yu H, Herbst RH, Hajaj E, Kiner E, Bamias A, De Santis M, Davis ID, Arranz JÁ, Kikuchi E, Bernhard S, Williams P, Lee C, Mellman I, Sanjabi S, Johnston R, Black PC, Grande E, Mariathasan S. Galsky MD, et al. Among authors: black pc. Cell Rep Med. 2024 Feb 20;5(2):101393. doi: 10.1016/j.xcrm.2024.101393. Epub 2024 Jan 26. Cell Rep Med. 2024. PMID: 38280376 Free PMC article. Clinical Trial.
Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin.
Chu CE, Sjöström M, Egusa EA, Gibb EA, Badura ML, Zhu J, Koshkin VS, Stohr BA, Meng MV, Pruthi RS, Friedlander TW, Lotan Y, Black PC, Porten SP, Feng FY, Chou J. Chu CE, et al. Among authors: black pc. Clin Cancer Res. 2021 Sep 15;27(18):5123-5130. doi: 10.1158/1078-0432.CCR-20-4175. Epub 2021 Jun 9. Clin Cancer Res. 2021. PMID: 34108177 Free PMC article.
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.
Klotz L, Chin J, Black PC, Finelli A, Anidjar M, Bladou F, Mercado A, Levental M, Ghai S, Chang SD, Milot L, Patel C, Kassam Z, Moore C, Kasivisvanathan V, Loblaw A, Kebabdjian M, Earle CC, Pond GR, Haider MA. Klotz L, et al. Among authors: black pc. JAMA Oncol. 2021 Apr 1;7(4):534-542. doi: 10.1001/jamaoncol.2020.7589. JAMA Oncol. 2021. PMID: 33538782 Free PMC article. Clinical Trial.
HER2 and urothelial carcinoma: current understanding and future directions.
Raggi D, Crupi E, Pederzoli F, Martini A, Briganti A, Alhalabi O, O'Donnell PH, Ross J, Gupta S, Kamat AM, Faltas BM, Black PC, Spiess PE, Grivas P, Gao J, Apolo AB, Huddart RA, Necchi A, Galsky MD. Raggi D, et al. Among authors: black pc. Nat Rev Urol. 2026 Feb;23(2):110-132. doi: 10.1038/s41585-025-01075-x. Epub 2025 Aug 15. Nat Rev Urol. 2026. PMID: 40817396 Review.
Reply by Author.
St-Laurent MP, Acland G, Hamilton SN, Hamm J, Sunderland K, Black PC, McKenzie M, Keyes M, Miller S, Gleave ME, Tyldesley S. St-Laurent MP, et al. Among authors: black pc. J Urol. 2024 Jul;212(1):73. doi: 10.1097/JU.0000000000004006. Epub 2024 May 7. J Urol. 2024. PMID: 38713553 No abstract available.
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.
Taylor JI, Kamat AM, O'Donnell MA, Annapureddy D, Howard J, Tan WS, McElree I, Davaro F, Yim K, Harrington S, Dyer E, Black AJ, Kanabur P, Roumiguié M, Lerner S, Black PC, Raman JD, Preston MA, Steinberg G, Huang W, Li R, Packiam VT, Woldu SL, Lotan Y. Taylor JI, et al. Among authors: black pc. BJU Int. 2025 Feb;135(2):260-268. doi: 10.1111/bju.16509. Epub 2024 Aug 25. BJU Int. 2025. PMID: 39183466 Free PMC article.
414 results